EDNRB and DCC salivary rinse hypermethylation has a similar performance as expert clinical examination in discrimination of oral cancer/dysplasia versus benign lesions

Clinical Cancer Research

Volumn 19, Issue 12, 2013, Pages 3268-3275

  Schussel, Juliana ^a   Zhou, Xian Chong ^b   Zhang, Zhe ^b   Pattani, Kavita ^a   Bermudez, Francisco ⁱ   Jean Charles, Germain ^h   McCaffrey, Thomas ^d   Padhya, Tapan ^j   Phelan, Joan ^d,e   Spivakovsky, Silvia ^d,e   Brait, Mariana ^a,k   Li, Ryan ^a   Bowne, Helen Yoo ^f   Goldberg, Judith D ^g   Rolnitzky, Linda ^g   Robbins, Miriam ^d,e   Kerr, A Ross ^d,e   Sirois, David ^d,e,l   Califano, Joseph A ^a,c  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c GREATER BALTIMORE MEDICAL CENTER   (United States)

^d Department of Oral Maxillofacial Pathology ^*  (Puerto Rico)

^e NEW YORK UNIVERSITY   (United States)

^f ST VINCENT S HOSPITAL   (United States)

^g NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY AT BUFFALO   (United States)

ⁱ UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^j H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^k INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^l NEW YORK UNIVERSITY COLLEGE OF DENTISTRY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ENDOTHELIN B RECEPTOR;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DCC GENE; DNA EXTRACTION; DNA METHYLATION; DYSPLASIA; EDNRB GENE; FEMALE; HIGH RISK POPULATION; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; MOUTH TUMOR; PRECANCER; PRIORITY JOURNAL; PROMOTER REGION; PROSPECTIVE STUDY; SALIVA; SENSITIVITY AND SPECIFICITY; TUMOR GENE;

DIAGNOSIS, DIFFERENTIAL; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOUTH NEOPLASMS; NEOPLASMS; PROMOTER REGIONS, GENETIC; RECEPTORS, CELL SURFACE; RECEPTORS, ENDOTHELIN; SALIVA; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 84879485625     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-12-3496     Document Type: Article

References (28)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63:11-30.
2. Goodwin WJ Jr. Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means? Laryngoscope 2000;110:1-18.
3. Patton LL. The effectiveness of community-based visual screening and utility of adjunctive diagnostic aids in the early detection of oral cancer. Oral Oncol 2003;39:708-23.
4. Mignogna MD, Fedele S, Lo Russo L. The World Cancer Report and the burden of oral cancer. Eur J Cancer Prev 2004;13:139-42.
5. Subramanian S, Sankaranarayanan R, Bapat B, Somanathan T, Thomas G, Mathew B, et al. Cost-effectiveness of oral cancer screening: results from a cluster randomized controlled trial in India. Bull World Health Organ 2009;87:200-6.
6. Nagao T, Warnakulasuriya S, Ikeda N, Fukano H, Fujiwara K, Miyazaki H. Oral cancer screening as an integral part of general health screening in Tokoname City, Japan. J Med Screen 2000;7:203-8.
7. Califano J, Westra WH, Koch W, Meininger G, Reed A, Yip L, et al. Unknown primary head and neck squamous cell carcinoma: molecular identification of the site of origin. J Natl Cancer Inst 1999;91:599-604.
8. Cianchetti M, Mancuso AA, Amdur RJ, Werning JW, Kirwan J, Morris CG, et al. Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknownhead and neck primary site. Laryngoscope 2009;119:2348-54.
9. Hoque MO, Begum S, Topaloglu O, Jeronimo C, Mambo E, Westra WH, et al. Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer. Cancer Res 2004;64:5511-7.
10. Hoque MO, Feng Q, Toure P, Dem A, Critchlow CW, Hawes SE, et al. Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer. J Clin Oncol 2006;24:4262-9.
11. Carvalho AL, Jeronimo C, Kim MM, Henrique R, Zhang Z, Hoque MO, et al. Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma. Clin Cancer Res 2008;14:97-107.
12. Nunes DN, Kowalski LP, Simpson AJ. Detection of oral and oropharyngeal cancer by microsatellite analysis in mouth washes and lesion brushings. Oral Oncol 2000;36:525-8.
13. Demokan S, Chang X, Chuang A, Mydlarz WK, Kaur J, Huang P, et al. KIF1A and EDNRB are differentially methylated in primary HNSCC and salivary rinses. Int J Cancer 2010;127:2351-9.
14. Kramer IR, Pindborg JJ, Bezroukov V, Infirri JS. Guide to epidemiology and diagnosis of oral mucosal diseases and conditions. World Health Organization. Community Dent Oral Epidemiol 1980;8:1-26.
15. Harden SV, Guo Z, Epstein JI, Sidransky D. Quantitative GSTP1 methylation clearly distinguishes benign prostatic tissue and limited prostate adenocarcinoma. J Urol 2003;169:1138-42.
16. Ragin CC, Modugno F, Gollin SM. The epidemiology and risk factors of head and neck cancer: a focus on human papillomavirus. J Dent Res 2007;86:104-14.
17. Pattani KM, Zhang Z, Demokan S, Glazer C, Loyo M, Goodman S, et al. Endothelin receptor typeBgene promoter hypermethylation in salivary rinses is independently associated with risk of oral cavity cancer and premalignancy. Cancer Prev Res (Phila) 2010;3:1093-103.
18. Warnakulasuriya S, Reibel J, Bouquot J, Dabelsteen E. Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement. J Oral Pathol Med 2008;37:127-33.
19. Fearon ER, Cho KR, Nigro JM, Kern SE, Simons JW, Ruppert JM, et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 1990;247:49-56.
20. Hedrick L, Cho KR, Fearon ER, Wu TC, Kinzler KW, Vogelstein B. The DCC gene product in cellular differentiation and colorectal tumorigenesis. Genes Dev 1994;8:1174-83.
21. Carvalho AL, Chuang A, Jiang WW, Lee J, Begum S, Poeta L, et al. Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma. Cancer Res 2006;66:9401-7.
22. Tamura G. Promoter methylation status of tumor suppressor and tumor-related genes in neoplastic and non-neoplastic gastric epithelia. Histol Histopathol 2004;19:221-8.
23. Miyamoto K, Fukutomi T, Akashi-Tanaka S, Hasegawa T, Asahara T, Sugimura T, et al. Identification of 20 genes aberrantly methylated in human breast cancers. Int J Cancer 2005;116:407-14.
24. Di Vinci A, Casciano I, Marasco E, Banelli B, Ravetti GL, Borzi L, et al. Quantitative methylation analysis of HOXA3, 7, 9, and 10 genes in glioma: association with tumor WHO grade and clinical outcome. J Cancer Res Clin Oncol 2012;138:35-47.
25. Guerrero-Preston R, Soudry E, Acero J, Orera M, Moreno-Lopez L, Macia-Colon G, et al. NID2 and HOXA9 promoter hypermethylation as biomarkers for prevention and early detection in oral cavity squamous cell carcinoma tissues and saliva. Cancer Prev Res (Phila) 2011;4: 1061-72.
26. Rosas SL, Koch W, daCosta Carvalho MG, Wu L, Califano J, Westra W, et al. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA- methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res 2001;61:939-42.
27. Zhao M, Rosenbaum E, Carvalho AL, Koch W, Jiang W, Sidransky D, et al. Feasibility of quantitative PCR-based saliva rinse screening of HPV for head and neck cancer. Int J Cancer 2005;117:605-10.
28. Lallemant B, Evrard A, Combescure C, Chapuis H, Chambon G, Raynal C, et al. Clinical relevance of nine transcriptional molecular markers for the diagnosis of head and neck squamous cell carcinoma in tissue and saliva rinse. BMC Cancer 2009;9:370.